Date
22 Jun 2026 - 25 Jun 2026
Venue
San Diego Convention Center, San Diego, CA, USA
BIO International Convention 2026 – Hong Kong Pavilion
Organiser: HKSTP
Co-organiser: Invest Hong Kong
Supporting Organisations: HKTDC, HKETO San Francisco
HKSTP is leading the largest-ever Hong Kong delegation to the BIO International Convention in San Diego from 22-25 June. Joining forces with five QS Top 100 universities, City University of Hong Kong, The Chinese University of Hong Kong, The Hong Kong Polytechnic University, The Hong Kong University of Science and Technology, The University of Hong Kong, we have doubled our exhibition footprint to showcase 41 breakthrough innovations. Together, we are highlighting next-generation therapeutics and diagnostics, reinforcing Hong Kong’s position as the premier gateway to global biotech success.
Event Highlights
- Date: 22 - 25 June 2026
- Venue: San Diego Convention Center, San Diego, CA, United States
- Hong Kong Pavilion Booth No.: 2211
Global Mixer 2026
Join us at the Hong Kong Pavilion as we co-host an 1-minute pitch session in collaboration with the Hong Kong Trade Development Council (HKTDC)
- Date: 22 -23 June 2026 (2 Days)
- Time: 14:15 – 15:30 (PDT)
- Venue: San Diego Convention Center, San Diego, CA, USA
- Hong Kong Pavilion Booth No.: 2211
- Participating Companies: 41 exhibitors
HKSTP Curated Pitching – From Showcase to Partnering
To further accelerate the impact of our I&T ecosystem, HKSTP is hosting two curated pitching sessions. This event will spotlight 18 selected biotech companies as they will present their innovations to a panel of world-class industry experts and investors.
Day 1: HKSTP Park Companies
- Date: 22 June 2026
- Time: 16:00 – 17:30 (PDT)
- Venue: San Diego Convention Center, San Diego, CA, USA
- Hong Kong Pavilion Booth No.: 2211
- Companies to pitch: 9 park companies
- Panelists:
- Friedemann Janus, PhD, SVP, Head of BD&L Regions, Co.Lab, Regional and Divestitures, Bayer
- Kamran Tavangar, PhD, MBA, Head of Science Strategy, LabCentral
- Qiusong Tang, PhD, Global Search & Evaluation Strategy Lead, Corporate Business Development, Roche / Genentech
- Zhou Gaobo, MBA, Chief Investment Officer, Simcere Pharmaceutical Group
- Michael Langer, BA, Co-Founder & Managing Partner, T.Rx Capital
- Sharon Chan, DPhil, MBA, MPH, Vice President, JLABS Asia Pacific, Johnson & Johnson
Day 2: University Spin-off & Park Companies
- Date: 23 June 2026
- Time: 16:00 – 17:30 (PDT)
- Venue: San Diego Convention Center, San Diego, CA, USA
- Hong Kong Pavilion Booth No.: 2211
- Companies to pitch: 9 University Spin-off & Park Companies
- Panelists:
- Friedemann Janus, PhD, SVP, Head of BD&L Regions, Co.Lab, Regional and Divestitures, Bayer
- Kamran Tavangar, PhD, MBA, Head of Science Strategy, LabCentral
- Sharon Chan, DPhil, MBA, MPH, Vice President, JLABS Asia Pacific, Johnson & Johnson
- Fei Shen, PhD, Head of BD&L USA & Global TA Inflammation, Boehringer Ingelheim
BIO 2026 – Breakout Session: Translating Innovation Across Borders: Creating Global Gateways for Biotech Startups
Join us for our breakout session, where global thought leaders will delve into the value, access opportunities, and strategic challenges shaping the international biotech landscape.
- Date: 23 June 2026
- Time: 15:00 – 16:00 (PDT)
- Venue: 30ABC, L1, San Diego Convention Center
- Moderator: Maggie O'Toole, President & CEO, LabCentral
- Speakers:
- Doug Crawford, General Manager, MBC BioLabs
- Falk Ehmann, MD, PhD, Head of Innovation and Development Accelerator, European Medicines Agency (EMA)
- Michelle A. Ottey, PdD, President, CIC Campuses and Labs, CIC
- Terry Wong, CEO, HKSTP
- Toshio Fujimoto, MD, CEO, iPark Institute Co. Ltd.
Hong Kong biotech companies and institutes exhibiting at the Hong Kong Pavilion (Listed alphabetically by English name; * denotes HKSTP Park companies)
Company Name
- 6J Biotechnology (Hong Kong) Limited*
- Advent Gene Therapeutics
- AiMorphous Healthtech Limited*
- Alternative Bio Limited*
- AniTech Limited
- Bone's Technology Limited*
- BriWhite Limited
- Canton Biologics (Hong Kong) Limited*
- CATUG International (Hong Kong) Limited*
- CELLmeric Limited
- Cellomics Holdings Limited*
- Cimple Biotechnology Limited*
- Cognitact Limited*
- Cytomics Limited*
- Delonix Bioworks
- EnKang Pharmaceuticals (Guangzhou), Ltd.
- ETERN Health HK Limited*
- Excalipoint Therapeutics Hong Kong Limited*
- GenEditBio Limited*
- Great Bay Bio Limited*
- Greater Bay Area International Clinical Trial Institute
- HighTide Therapeutics (Hong Kong) Limited*
- Homing Therapeutics Limited*
- Hong Kong DPBIO Technology Limited
- Hong Kong Inhal Pharma Company Limited*
- HongKong Curegene Innovation Co., Limited*
- Hongkong Secretech Limited*
- Immuno Cure Holding (HK) Limited*
- InxMed (Hong Kong) Limited*
- Lee’s Pharmaceutical (HK) Limited*
- MediOrigin Technology Limited
- Meta Pharmaceuticals (HK) Limited*
- NutrigeneAI Biotech Limited*
- Oncoimmunostics Ltd*
- Orange Biotech Limited*
- Recorna (Hong Kong) Biotechnology Co., Limited*
- SPH Biotherapeutics (HK) Limited*
- Stemax Regenerative Medicine Technology Limited*
- StickyCell Hong Kong Limited*
- The Hong Kong Polytechnic University
- Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited*
About Global Mixer
Global Mixer is an outreach programme aimed at collaborating with enterprises, investors and talent from around the world, with the goal of advancing our I&T ecosystem. We bring Hong Kong’s brightest innovators out of the city to showcase their pioneering solutions, while connecting them with investors and industry leaders to unlock powerful cross-border partnerships.